Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition
- PMID: 40303985
- PMCID: PMC12040325
- DOI: 10.1016/j.mehy.2024.111266
Neuron-Targeted Exosome Therapy: A Novel Approach for Treating Cardiogenic Dementia via RyR2 Inhibition
Abstract
Cardiogenic dementia (CD), recognized since the late 1970s, manifests as altered consciousness and cognition due to heart conditions. Its elusive molecular mechanisms present diagnostic and management challenges. Emerging research implicates ryanodine receptor type 2 (RyR2) mediated intracellular Ca2+ leaks in myocardial infarction (MI)-linked cognitive impairment. We hypotheses that intravenous delivery of neuron-targeted exosomes loaded with RyR2-targeting siRNA (si-RyR2) to cerebral regions could rectify Ca2+ imbalance, curbing neurotoxic protein generation tied to CD. To investigate, si-RyR2 exosomes will be administered to MI-induced mice, with hippocampal samples analyzed for Ca2+ levels, β-amyloid, and p-tau. Results hold promise for advancing CD treatment insights.
Keywords: Cardiogenic dementia; exosome; myocardial infarction; neuron-targeted peptides; ryanodine receptor 2 (RyR2).
Conflict of interest statement
Conflicts of interest: none
References
-
- Small GW, et al. , Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA, 1997. 278(16): p. 1363–71. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
